Skip to main content

Patients with hereditary hemochromatosis lack Q10

- and supplements may have therapeutic value

Patients with hereditary hemochromatosis lack Q10Hereditary hemochromatosis is a group of diseases that involve iron accumulation in the body. This leads to oxidative stress and tissue destruction which may affect the liver and other organs. According to a new Argentinian study, patients with hereditary hemochromatosis lack Q10 in their blood. Because Q10 is of vital importance to the cellular energy turnover and it also serves as a powerful antioxidant against oxidative stress, a Q10 deficiency will contribute to the disease. This, the researchers behind the new study explain, is why Q10 may represent a new and safe agent for treating the condition.